Image
01.03.2021
Meeting the Duke and Duchess of Cambridge
One of our supporters has met the Duke and Duchess of Cambridge to speak about diabetes and other health ...
customer support
customer support
From research findings supporting SGLT-2 inhibitors as a first-choice type 2 treatment to a real-world study strengthening evidence for teplizumab in early type 1, here are some of the diabetes research developments announced in February 2026.
Read more